SIRIN-LABS
11.7.2018 16:52:05 CEST | Business Wire | Press release
SIRIN LABS (https://sirinlabs.com/ ) the company that ended 2017 with the fourth largest crowdsale in history by raising $157.8M, is unveiling the final design of the FINNEY™, the first ever blockchain smartphone. The uniquely designed FINNEY™, due to hit markets this November, contains a “Safe Screen” — a standalone screen that functions on dedicated firmware and will be able to independently verify that FINNEY™ wallet transactions are being sent to the correct addresses, allowing users to verify they’re not being tricked by malware or hackers to send their cryptocurrencies or tokens to a fraudulent third party.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180711005563/en/
The FINNEY™ smartphone will run on SIRIN LABS’ proprietary operating system, SIRIN OS™, which is an ultra- secure and Google-certified “fork” of Android, and will showcase four main features:
- An embedded cold storage wallet.
- A comprehensive and multi-layer cybersecurity suite.
- A Token Conversion Service (TCS).
- A multi-blockchain DApp store.
FINNEY™ users will be able to activate the embedded cold storage wallet by sliding-up the “Safe Screen.” Combined with the multi-layered SIRIN OS™ security suite and Token Conversion Service, the FINNEY™ will enable safe, secure, and seamless automatic token conversions for various purposes, including purchases for decentralized applications within the SIRIN LABS DApp store. These conversions can be completed without the unnecessary inconvenience of obtaining tokens through an exchange; thus simplifying the complicated user experience.
FIH Mobile (Foxconn International Holdings) has been chosen to manufacture the phone, while SIRIN LABS is leading the development of the cold storage wallet and of SIRIN OS™.
FINNEY ™’s Design:
- Sleek and expressive design articulating the vision of the SIRIN LABS aesthetic.
- 3D Gorilla Glass on both the front and back of the device.
- Matte back cover 3D glass.
- High gloss, concave metal frame.
- Thin bezel and notch display.
- Metallic signature Shield Element accommodating the camera, sensors, and fingerprint scanner.
- Secured touch “Safe Screen ” for the built-in cold storage wallet to protect against malicious attacks.
- The unique sliding design “warms” (activates) the cold storage wallet, which readies it for use when opened.
- User experience designed to cater to the needs of crypto experts and novices alike.
Zvika Landau, Co-CEO, SIRIN LABS: “Our team is honored to present the design for the FINNEY™ blockchain smartphone to the world. We’ve been working around-the-clock to provide our users with a multi-layer cyber protection suite to guard them from network attacks, host attacks, and malware fishing. The secured layers, combined with our revolutionary “Safe Screen” and the ultra-sleek design, enable us to offer our users comprehensive levels of cyber protection. This truly remarkable combination of protection, software, and the design of the phone, cohesively transforms the mobile environment into one that is secure enough for cryptocurrency transactions.”
Click here to watch a 360 video of the design: https://www.youtube.com/watch?v=5GE3lwa-ixY&feature=youtu.be
About SIRIN LABS
SIRIN LABS is developing the FINNEY™ — the premier open source, ultra-secure blockchain smartphone with an embedded cold storage crypto wallet. Our vision is to bridge the gap between the blockchain economy and the mass market by solving the two greatest barriers to the crypto market: security and user experience. After concluding 2017 with the 4th largest ICO in history, SIRIN LABS has already established strategic partnerships with industry leaders like Cardano and FIH (Foxconn International Holdings- makers of the iPhone, Xbox and Kindle), and has signed on the football superstar, FC Barcelona’s Leo Messi, as its official global Brand Ambassador. FINNEY™ will run on SIRIN OS™, an ultra- secure and Google-certified “fork” of Android.
Learn more at: sirinlabs.com
Follow us on Telegram: https://t.me/sirinlabs .
View source version on businesswire.com: https://www.businesswire.com/news/home/20180711005563/en/
Contact:
Media Contacts:
Blonde: Alona Stein, +972-50-778-2344
alona@blonde20.com
or
SIRIN
LABS: Nimrod May, +972-54-480-1308
nimrodm@sirinlabs.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Earnix Brings Agentic AI to the Decisions That Drive Insurance Performance17.9.2026 15:09:00 CEST | Press release
Agent Hub, part of Earnix AIOS, brings more than 25, insurance-specific agents and apps into Earnix’s governed pricing, underwriting, and customer decision solutions- improving workflows and business performance Earnix today announced the introduction of Agent Hub, a curated catalog of insurance-specific AI agents and apps within Earnix AIOS — the AI Orchestration System powering Earnix’s pricing and rating, underwriting, and customer engagement solutions. Agent Hub brings agentic AI directly into these solutions, enabling more intelligent workflows and strengthening the high-stakes decisions that shape pricing, underwriting, customer engagement, growth, and profitability. In an increasingly turbulent insurance environment, the useful life of an insurance decision is getting shorter. Risk and market conditions are changing faster, making growth, profitability, and portfolio performance harder to manage. AI is increasing the speed and scope of what insurers can analyze, recommend, and i
Medisca Launches Global Peptide Division17.9.2026 15:07:00 CEST | Press release
New division brings API-grade peptides and Medisca’s quality-first pharmaceutical expertise to a rapidly evolving area of personalized medicine Medisca today announced the launch of Medisca Peptides, a dedicated global division focused on expanding access to API-grade peptides and building an integrated peptide platform for pharmaceutical and personalized medicine markets worldwide. As the peptide landscape evolves, Medisca is proactively building the capabilities and infrastructure needed to support API-grade peptides within applicable regulatory frameworks. The launch represents a significant long-term commitment to peptides, including the expansion of Medisca’s portfolio, strategic manufacturing relationships, and the pharmaceutical infrastructure needed to support the category’s growth. It also signals Medisca’s ambition to become a leading force in the next generation of peptide innovation. For Medisca, the opportunity is familiar. More than 35 years ago, the company was founded t
Elliptic Launches Its Decode Agent to Answer On-Chain Risk Questions and Shows Its Work17.9.2026 15:00:00 CEST | Press release
Hours of tracing, answered in seconds, with the evidence attached Elliptic, the global leader in on-chain risk, today launched Decode, an AI agent built on Elliptic’s intelligence platform. The Decode agent answers natural-language questions about cryptoasset addresses and their exposure in seconds, and returns the evidence behind every answer. Compliance and investigations teams need answers to questions nobody planned for. Getting them out of the data is now a specialist skill, so the questions wait for someone who has it, or go unasked. Meanwhile illicit actors move at machine speed, and agents are starting to sit on both sides of a payment. General-purpose AI assistants can produce an answer. They cannot show where it came from. A fluent response with nothing behind it cannot be put in front of a second-line reviewer, an auditor, or a regulator. “The market is full of AI that asks to be trusted. That is not good enough when someone asks how you reached a decision,” said Jackson Hul
AMRA Medical Earns TIME’s Highest “Outstanding” Rating in World’s Top HealthTech Companies 202617.9.2026 14:51:00 CEST | Press release
AMRA is the only European company in the Diagnostics segment to receive the highest designation, recognizing its work in MRI-based muscle and fat analysis. The 2026 result builds on AMRA’s inclusion in the inaugural ranking in 2025, when the company received a “Very High” designation. Its advancement to the top category reflects continued progress in scientific excellence and technological innovation, as well as the expanding application of MRI-based biomarkers across research, drug development, and clinical care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260917956850/en/ “Being recognized by TIME and Statista for the second consecutive year and receiving the highest ‘Outstanding’ designation is a meaningful recognition of AMRA’s continued progress,” said Olof Dahlqvist Leinhard, CEO of AMRA Medical. “It reflects the dedication of our team and the strong scientific foundation behind our work. Our mission is to advance t
INNIO Secures 450 MW Order to Power Next-Generation Data Centers17.9.2026 14:30:00 CEST | Press release
U.S. based energy company orders Jenbacher J624 containerized engines to support deployment of fast-track, behind-the-meter power solutions for large-scale data centers 450 MW firm order booked in Q3 2026 INNIO N.V. (Nasdaq: INIO) today announced it has secured an order from a U.S. energy company for 450 megawatts (MW) of power infrastructure. INNIO's Jenbacher J624 containerized gas engines will support the deployment of prime power solutions for large-scale data center projects in North America. The order reflects continued demand for the company's high-efficiency gas engine technology as data center developers seek off-grid alternatives to constrained grid infrastructure. This is the first order by the customer of this scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260917646026/en/ INNIO secures 450 MW order to power next-generation data centers The engines are expected to be delivered by 2028. The firm order was b
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom